Pathology of rodent models of intestinal cancer: Progress report and recommendations

Gastroenterology

Volumn 144, Issue 4, 2013, Pages 705-717

  Washington, Mary Kay ^a   Powell, Anne E ^a   Sullivan, Ruth ^c   Sundberg, John P ^a,d   Wright, Nicholas ^e,f   Coffey, Robert J ^a,b,g   Dove, William F ^h  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d JACKSON LABORATORY   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Animal; Disease Models; Genetically Engineered Mice; Intestinal Neoplasms; Pathology

Indexed keywords

BIOLOGICAL MARKER;

ABERRANT CRYPT FOCUS; ADENOCARCINOMA; ADENOMA; ANIMAL MODEL; CELL LINEAGE; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CARCINOMA; GENE MUTATION; GENETIC MODEL; GOBLET CELL; HERNIA; HIGH RISK PATIENT; HUMAN; HYPERPLASIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE CANCER; MOUSE; NOMENCLATURE; NONHUMAN; PATHOLOGY; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TUMOR CELL; WORLD HEALTH ORGANIZATION;

EID: 84875244212     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.01.067     Document Type: Review

References (70)

1. G.P. Boivin, K. Washington, K. Yang Pathology of mouse models of intestinal cancer: consensus report and recommendations Gastroenterology 124 2003 762 777
2. M.M. Taketo, W. Edelmann Mouse models of colon cancer Gastroenterology 136 2009 780 798
3. J.M. Fischer, A.J. Miller, D. Shibata Different phenotypic consequences of simultaneous versus stepwise Apc loss Oncogene 31 2012 2028 2038
4. A.A. Leystra, D.A. Deming, C.D. Zahm Mice expressing activated PI3K rapidly develop advanced colon cancer Cancer Res 72 2012 2931 2936
5. A.J. Miller, S.D. Dudley, J.-L. Tsao Tractable Cre-lox system for stochastic alteration of genes in mice Nat Methods 5 2008 227 229
6. M.H. Kucherlapati, K. Lee, A.A. Nguyen An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents Gastroenterology 138 2010 993 1002 e1
7. J.C. Arthur, E. Perez-Chanona, M. Muhlbauer Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 2012 120 123
8. S.I. Grivennikov, K. Wang, D. Mucida Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth Nature 491 2012 254 258
9. C.A. O'Brien, A. Pollett, S. Gallinger A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106 110
10. L. Ricci-Vitiani, D.G. Lombardi, E. Pilozzi Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
11. S.R. Hamilton, L.A. Aaltonen World Health Organization classification of tumours Pathology and genetics of tumours of the digestive system 2000 International Agency for Research on Cancer Lyon, France
12. R.D. Odze, R.H. Riddell, F.T. Bosman Premalignant lesions of the digestive system F.T. Bosman, F. Carneiro, R.H. Hruban, World Health Organization classification of tumours of the digestive system 2012 International Agency for Research on Cancer Lyon, France 10 12
13. M. Bennecke, L. Kriegl, M. Bajbouj Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis Cancer Cell 18 2010 135 146
14. F.R. Greten, L. Eckmann, T.F. Greten IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 2004 285 296
15. A. Bissahoyo, R.S. Pearsall, K. Hanlon Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet Toxicol Sci 88 2005 340 345
16. J.M. Uronis, H.H. Herfarth, T.C. Rubinas Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage Cancer Res 67 2007 11594 11600
17. A. Papanikolaou, Q.S. Wang, D. Papanikolaou Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis Carcinogenesis 21 2000 1567 1572
18. Q. Lu, B. Jiang, C. Lin Dark aberrant crypt foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat J Exp Clin Cancer Res 27 2008 26
19. J.E. Paulsen, E.M. Loberg, H.B. Olstorn Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat Cancer Res 65 2005 121 129
20. L. Johnson, K. Mercer, D. Greenbaum Somatic activation of the K-ras oncogene causes early onset lung cancer in mice Nature 410 2001 1111 1116
21. G. Caderni, A.P. Femia, A. Giannini Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis Cancer Res 63 2003 2388 2392
22. A.P. Femia, B. Bendinelli, A. Giannini Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats Int J Cancer 116 2005 9 15
23. A.P. Femia, A. Giannini, M. Fazi Identification of mucin depleted foci in the human colon Cancer Prev Res 1 2008 562 567
24. A.P. Femia, P. Dolara, G. Caderni Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis Carcinogenesis 25 2004 277 281
25. F. Pierre, R. Santarelli, S. Tache Beef meat promotion of dimethylhydrazine-induced colorectal carcinogenesis biomarkers is suppressed by dietary calcium Br J Nutr 99 2008 1000 1006
26. A.P. Femia, P. Dolara, A. Giannini Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis Cancer Research 67 2007 445 449
27. A.P. Femia, E. Tarquini, M. Salvadori K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine Int J Cancer 122 2008 117 123
28. J.M. Amos-Landgraf, L.N. Kwong, C.M. Kendziorski A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer Proc Natl Acad Sci U S A 104 2007 4036 4041
29. A.R. Moser, H.C. Pitot, W.F. Dove A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse Science 247 1990 322 324
30. A.A. Irving, R.B. Halberg, D.M. Albrecht Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models Arch Biochem Biophys 515 2011 64 71
31. A.E. Powell, Y. Wang, Y. Li The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor Cell 149 2012 146 158
32. J. Bollrath, T.J. Phesse, V.A. von Burstin gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis Cancer Cell 15 2009 91 102
33. L. Deng, J.-F. Zhou, R.S. Sellers A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis Am J Pathol 176 2010 952 967
34. N.M. Sodir, X. Chen, R. Park Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice Cancer Res 66 2006 8430 8438
35. N.M. Munoz, M. Upton, A. Rojas Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation Cancer Res 66 2006 9837 9844
36. P. Trobridge, S. Knoblaugh, M.K. Washington TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway Gastroenterology 136 2009 1680 1688.e7
37. K.E. Hung, M.A. Maricevich, L.G. Richard Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment Proc Natl Acad Sci U S A 107 2010 1565 1570
38. E.L. Jackson, N. Willis, K. Mercer Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras Genes Dev 15 2001 3243 3248
39. A.Y. Nikitin, A. Alcaraz, M.R. Anver Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium Cancer Res 64 2004 2307 2316
40. T.K. Starr, R. Allaei, K.A.T. Silverstein A transposon-based genetic screen in mice identifies genes altered in colorectal cancer Science 323 2009 1747 1750
41. T.K. Starr, P.M. Scott, B.M. Marsh A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis Proc Natl Acad Sci U S A 108 2011 5765 5770
42. H.N. March, A.G. Rust, N.A. Wright Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis Nat Genet 43 2011 1202 1209
43. K.T. Nam, H.-J. Lee, J.J. Smith Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas J Clin Invest 120 2010 840 849
44. T. Hinoi, A. Akyol, B.K. Theisen Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation Cancer Res 67 2007 9721 9730
45. I. Mikaelian, L.B. Nanney, K.S. Parman Antibodies that label paraffin-embedded mouse tissues: a collaborative endeavor Toxicol Pathol 32 2004 181 191
46. C.M. van der Loos, H. Gobel The animal reearch kit (ARK) can be used in a multi-step double staining method for human tissue specimens J Histochem Cytochem 48 2000 1431 1438
47. E. Bjorling, M. Uhlen Antibodypedia, a portal for sharing antibody and antigen validation data Mol Cell Proteomics 7 2008 2028 2037
48. J. Bordeaux, A. Welsh, S. Agarwal Antibody validation Biotechniques 48 2010 197 209
49. K. Kretzschmar, F.M. Watt Lineage tracing Cell 148 2012 33 45
50. N. Barker, J.H. van Es, J. Kuipers Identification of stem cells in small intestine and colon by marker gene Lgr5 Nature 449 2007 1003 1007
51. E. Sangiorgi, M.R. Capecchi Bmi1 is expressed in vivo in intestinal stem cells Nature Genetics 40 2008 915 920
52. D.T. Breault, I.M. Min, D.L. Carlone Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells Proc Natl Acad Sci U S A 105 2008 10420 10425
53. N. Takeda, R. Jain, M.R. LeBoeuf Interconversion between intestinal stem cell populations in distinct niches Science 334 2011 1420 1424
54. C. Lopez-Garcia, A.M. Klein, B.D. Simons Intestinal stem cell replacement follows a pattern of neutral drift Science 330 2010 822 825
55. H.J. Snippert, L.G. van der Flier, T. Sato Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells Cell 143 2010 134 144
56. H. Tian, B. Biehs, S. Warming A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable Nature 478 2011 255 259
57. N. Barker, A. van Oudenaarden, H. Clevers Identifying the stem cell of the intestinal crypt: strategies and pitfalls Cell Stem Cell 11 2012 452 460
58. Buczacki SJZ, Zecchini HI, Nicholson AM, et al. Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature (in press).
59. H.J. Snippert, J.H. van Es, M. van den Born Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine Gastroenterology 136 2009 2187 2194 e1
60. L.G. van der Flier, M.E. van Gijn, P. Hatzis Transcription factor achaete scute-like 2 controls intestinal stem cell fate Cell 136 2009 903 912
61. N. Barker, R.A. Ridgway, J.H. van Es Crypt stem cells as the cells-of-origin of intestinal cancer Nature 457 2009 608 611
62. A.G. Schepers, H.J. Snippert, D.E. Stange Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas Science 337 2012 730 735
63. S. Schwitalla, A.A. Fingerle, P. Cammareri Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties Cell 152 2013 25 38
64. A.F. Cheung, A.M. Carter, K.K. Kostova Complete deletion of Apc results in severe polyposis in mice Oncogene 29 2010 1857 1864
65. K.M. Haigis, K.R. Kendall, Y. Wang Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon Nat Genet 40 2008 600 608
66. N. Harada, Y. Tamai, T. Ishikawa Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene EMBO J 18 1999 5931 5942
67. L. Zhu, P. Gibson, D.S. Currle Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation Nature 457 2009 603 607
68. Y. Feng, G.T. Bommer, J. Zhao Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool Gastroenterology 141 2011 1003 1013 e1-10
69. O.J. Sansom, V. Meniel, J.A. Wilkins Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo Proc Natl Acad Sci U S A 103 2006 14122 14127
70. Y. Nakanishi, H. Seno, A. Fukuoka Dclk1 distinguishes between tumor and normal stem cells in the intestine Nat Genet 45 2012 98 103